Home › Funds › Almitas Capital LLC › RLYB
Almitas Capital LLC position in RLYB
RALLYBIO CORP · Health Care
Almitas Capital LLC reported holding 120,682 shares of RLYB (RALLYBIO CORP) in its Q2 2026 13F filing — a position valued at US$1.9M, representing 0.46% of its reported portfolio and ranking #46 among its reported holdings. Almitas Capital LLC has disclosed RLYB holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Almitas Capital LLC's RLYB position evolved
Almitas Capital LLC first disclosed a stake in RLYB in Q2 2024 at 100,876 shares (US$135K). The position peaked in Q2 2026 at 120,682 shares, worth US$1.9M. Across 9 filings, Almitas Capital LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 120,682 shares valued at US$1.9M — a reduction of -70,524 shares quarter over quarter.. Notable position changes include a 768% increase in Q3 2024 (shares fell 18% over the following quarter), a 48% increase in Q4 2024 (shares fell 32% over the following quarter), a 88% trim in Q1 2026 (shares rose 78% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 100.88K | $135.17K | New |
| Q3 2024 | 875.43K | $1.02M | Add |
| Q4 2024 | 1.30M | $1.25M | Add |
| Q1 2025 | 1.30M | $851.23K | Hold |
| Q2 2025 | 1.82M | $614.31K | Add |
| Q3 2025 | 1.54M | $767.83K | Reduce |
| Q4 2025 | 1.53M | $1.05M | Reduce |
| Q1 2026 | 191.21K | $1.72M | Reduce |
| Q2 2026 | 120.68K | $1.93M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RLYB and 13F data
RLYB (RALLYBIO CORP) is a Health Care company. 24 other funds we track also report a position in RLYB — the largest reported positions include ADAR1 Capital Management, LLC (US$14.8M), TPG GP A, LLC (US$6.1M), Pivotal bioVenture Partners Investment Advisor LLC (US$4.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RLYB
- ADAR1 Capital Management, LLC 926.35K sh · $14.82M · Q2 2026
- TPG GP A, LLC 378.55K sh · $6.06M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 300.58K sh · $4.81M · Q2 2026
- Rangeley Capital, LLC 104.85K sh · $1.68M · Q2 2026
- AJU IB Investment Co., Ltd. 94.33K sh · $846.18K · Q1 2026
More on Almitas Capital LLC
FAQ
How long has Almitas Capital LLC held RLYB?
Almitas Capital LLC has disclosed RLYB holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
What is Almitas Capital LLC's current position in RLYB?
As of Q2 2026, Almitas Capital LLC holds 120.68K shares of RLYB (RALLYBIO CORP), valued at $1.93M, representing 0.46% of its reported portfolio and ranking #46.
Has Almitas Capital LLC been buying or selling RLYB?
In the latest 13F filing (Q2 2026), Almitas Capital LLC reduced its position in RLYB. The position peaked in Q2 2026 at 120.68K shares.
Which other funds hold RLYB?
Other major institutional holders of RLYB include ADAR1 Capital Management, LLC, TPG GP A, LLC, Pivotal bioVenture Partners Investment Advisor LLC, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.